Javier Rodriguez insider trades

Open-market stock purchases and sales by Javier Rodriguez, Chief Executive Officer at Davita Inc, from SEC Form 4 filings since Mar 2, 2010.

Recent trades

DateStockTradeValue
Jun 16, 2026DVA Davita IncSold$8.2M
Jun 15, 2026DVA Davita IncSold$6.3M
Jun 15, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
May 20, 2026BTAI BioXcel Therapeutics, IncSold$7.1K
May 4, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
May 1, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Apr 30, 2026GILD Gilead Sciences, IncBought (not open market)—
Apr 30, 2026GILD Gilead Sciences, IncBought (not open market)—
Mar 15, 2026DVA Davita IncBought (not open market)—
Mar 15, 2026DVA Davita IncBought (not open market)—
Mar 15, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Mar 14, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Jan 1, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Dec 15, 2025BTAI BioXcel Therapeutics, IncBought (not open market)—
Dec 14, 2025BTAI BioXcel Therapeutics, IncBought (not open market)—
Nov 15, 2025DVA Davita IncSold (not open market)$628K

Companies traded

  • DVA Davita Inc: 34 sales, last Jun 16, 2026
  • BTAI BioXcel Therapeutics, Inc: 7 sales, last Jun 15, 2026
  • GILD Gilead Sciences, Inc: 1 sale, last Apr 30, 2026
  • BTAI ] BioXcel Therapeutics, Inc: 2 sales, last Dec 16, 2024

Get free alerts when Javier Rodriguez files a new trade →